Veranex

Veranex is a global service provider that specializes in the medical technology sector, offering comprehensive, technology-enabled solutions from concept to commercialization. The company focuses exclusively on various areas within medical technology, including medical devices, diagnostics, companion diagnostics, digital health, and drug delivery. Veranex provides a wide range of services, such as design and engineering, regulatory support, clinical trials, and market access, enabling clients to streamline their development processes. By addressing the entire clinical trial journey, Veranex helps clients accelerate their time to market, enhance market viability, manage development costs, and reduce associated risks.

Patrick Donnelly

CEO and Executive Chairman

4 past transactions

Experien Group

Acquisition in 2021
Provider of regulatory, quality and clinical consulting services to medtech companies. The company provides regulatory affairs, quality systems, pre-clinical and clinical, data and biostatistics consulting services to its clients.

Quartesian

Acquisition in 2021
Quartesian is a pharmaceuticals company based in Princeton, New Jersey, specializing in clinical data management services. The company provides a range of offerings, including biostatistics, statistical programming, medical writing, pharmacovigilance, and data visualization. By delivering these services, Quartesian aims to assist organizations in effectively managing their data and optimizing their clinical trials.

Boston Healthcare

Acquisition in 2021
Operator of a global strategy consulting firm intended to help innovators capture value in a complex and rapidly changing healthcare landscape. The company develops market access and value optimization strategies for emerging and established medical devices, diagnostics and pharmaceutical companies seeking to commercialize specialized products and services that have the potential to transform standards of care and significantly improve health outcomes.

Ximedica

Acquisition in 2021
For over 30 years Ximedica has led the industry in unearthing new opportunities for clients, solving difficult development challenges, delivering cutting edge innovative solutions, and adding considerably to patent counts. Our clients break into new markets or forge entirely new ones, are heralded for their award-winning designs and consistently beat sales targets. We have long understood that innovation benefits from diversity. Highly experienced, cross-disciplinary teams guide development programs and serve as a retained knowledge base, which decreases the development timeline. Ximedica is committed to quality and regulatory assurance as demonstrated by our ISO 13485:2003 certification.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.